Mesenchymal stem cells in the reconstruction surgery of the
supraspinatus muscle lesions

J 2017

Mesenchymal stem cells in the reconstruction surgery of the supraspinatus muscle lesions

ŠMÍD, Petr, Martin KOMZÁK, Radek HART a Libor PAŠA

Základní údaje

Originální název

Mesenchymal stem cells in the reconstruction surgery of the supraspinatus muscle lesions

Autoři

ŠMÍD, Petr (203 Česká republika, domácí), Martin KOMZÁK (203 Česká republika), Radek HART (203 Česká republika, garant) a Libor PAŠA (203 Česká republika, domácí)

Vydání

Clinical Investigation, London, Future Science, 2017, 2041-6792

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30211 Orthopaedics

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Kód RIV

RIV/00216224:14110/17:00097595

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

Bone marrow stem cells; rotator cuff lesion

Štítky

EL OK

Příznaky

Recenzováno

Změněno: 19. 3. 2018 13:51, Soňa Böhmová

Anotace

V originále

The objective of the study was to demonstrate the effect of concentrated bone marrow stem cells (MSCs) to the healing of sutured tendon of the supraspinatus muscle in comparison to the same procedure performed without MSCs. We have postulated the hypothesis that MSCs enhance the healing of the sutured supraspinatus tendon to its humeral footprint. Methods and findings: None of the patients had to be excluded from our prospective randomized study. 50 patients met the indication criteria for isolated supraspinatus surgery. 25 patients (Group I) received MSCs into the supraspinatus footprint. 25 patients (Group II) was treated without the use of MSCs. Patients were examined pre-operatively, 6, 12 and 24 months after the surgery and assessment included physical examination, visual analogue scale (VAS), ASES (American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form) and Constant score. Patients underwent MRI 2 years postoperatively. Findings were compared with the preoperative results. We have found no statistically significant differences between both groups pre-operatively. After a 24-month follow-up period there were significant differences observed in all clinical outcomes. When compared results between both groups two years postoperatively, p-value (p=0.05) for the VAS score was 0.0176 and for the Constant score 0.0355. The only statistically non-significant was p-value for the ASES score comparing results from both groups at two years follow-up (p=0.085). The MRI findings at 2 years showed fully healed tissue of the rotator cuff tendon in 17 patients in the Group I, but only in 9 patients in the Group II. Conclusions: We have accepted the hypothesis that MSCs enhance the healing of the sutured supraspinatus tendon to its humeral footprint.

Citovat

ŠMÍD, Petr, Martin KOMZÁK, Radek HART a Libor PAŠA. Mesenchymal stem cells in the reconstruction surgery of the supraspinatus muscle lesions. Clinical Investigation. London: Future Science, 2017, roč. 7, č. 2, s. 103-110. ISSN 2041-6792.

@article{1389911,
   author = {Šmíd, Petr and Komzák, Martin and Hart, Radek and Paša, Libor},
   article_location = {London},
   article_number = {2},
   keywords = {Bone marrow stem cells; rotator cuff lesion},
   language = {eng},
   issn = {2041-6792},
   journal = {Clinical Investigation},
   title = {Mesenchymal stem cells in the reconstruction surgery of the supraspinatus muscle lesions},
   volume = {7},
   year = {2017}
}

TY  - JOUR
ID  - 1389911
AU  - Šmíd, Petr - Komzák, Martin - Hart, Radek - Paša, Libor
PY  - 2017
TI  - Mesenchymal stem cells in the reconstruction surgery of the supraspinatus muscle lesions
JF  - Clinical Investigation
VL  - 7
IS  - 2
SP  - 103-110
EP  - 103-110
PB  - Future Science
SN  - 20416792
KW  - Bone marrow stem cells
KW  - rotator cuff lesion
N2  - The objective of the study was to demonstrate the effect of concentrated bone marrow stem cells (MSCs) to the healing of sutured tendon of the supraspinatus muscle in comparison to the same procedure performed without MSCs. We have postulated the hypothesis that MSCs enhance the healing of the sutured supraspinatus tendon to its humeral footprint. Methods and findings: None of the patients had to be excluded from our prospective randomized study. 50 patients met the indication criteria for isolated supraspinatus surgery. 25 patients (Group I) received MSCs into the supraspinatus footprint. 25 patients (Group II) was treated without the use of MSCs. Patients were examined pre-operatively, 6, 12 and 24 months after the surgery and assessment included physical examination, visual analogue scale (VAS), ASES (American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form) and Constant score. Patients underwent MRI 2 years postoperatively. Findings were compared with the preoperative results. We have found no statistically significant differences between both groups pre-operatively. After a 24-month follow-up period there were significant differences observed in all clinical outcomes. When compared results between both groups two years postoperatively, p-value (p=0.05) for the VAS score was 0.0176 and for the Constant score 0.0355. The only statistically non-significant was p-value for the ASES score comparing results from both groups at two years follow-up (p=0.085). The MRI findings at 2 years showed fully healed tissue of the rotator cuff tendon in 17 patients in the Group I, but only in 9 patients in the Group II. Conclusions: We have accepted the hypothesis that MSCs enhance the healing of the sutured supraspinatus tendon to its humeral footprint.
ER  -

ŠMÍD, Petr, Martin KOMZÁK, Radek HART a Libor PAŠA. Mesenchymal stem cells in the reconstruction surgery of the supraspinatus muscle lesions. \textit{Clinical Investigation}. London: Future Science, 2017, roč.~7, č.~2, s.~103-110. ISSN~2041-6792.

Podrobný výpis o publikaci